Evaluation of Drug Dosing in Renal Failure

Mohamed A. Hammad, M and Ahmed A. Khamis, A and Khaled M. Al- Akhali, K and Tarek M. Elsayed, T and Ashwag M. Alasmri, A and Eman M. Al-Ahmari, E and Enas M. Mossa, E and Nada M. Al-Gahtani, N and Yasmin El-Sobky, Y (2016) Evaluation of Drug Dosing in Renal Failure. IOSR Journal of Pharmacy and Biological Sciences, 11 (5). pp. 39-50. ISSN 2278-3008

29.evaluation of drug dosing in renal dysfunction.pdf

Download (914kB) | Preview
Official URL: https://www.researchgate.net/profile/Mohamed_Hamma...


Introduction: Rapid accumulation and toxicity can be developed if drugs dosages are not adjusted in patients with chronic kidney diseases (CKD). Objectives: To evaluate the prevalence of correct dosing in chronic kidney diseases depending on renal function estimation. Study Design: A cross-sectional observational study involving patients in medical ward from January to July 2014 at Aseer Central Hospital in Abha, Kingdom of Saudi Arabia Methods: Demographic data were collected from patients, patients' files and healthcare providers. Dosage adjustment depends on the patients’ kidney function, most often estimated by the patient's glomerular filtration rate (eGFR) calculated by the CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration) and a computerized system was used to determine the adjusted renal dose. Results: From total 2470 prescribed drugs for 362 inpatients, 420 (17%) drugs need a dosing adjustment in chronic renal failure and 2050 (83%) drugs do not need. From the 420 drugs that need a dosing adjustment, the dose of 202 (48.1%) drugs were adjusted, and of 218 (51.9%) drugs were not. Drugs that need a readjustment are allopurinol, ampicillin, cefepime, cefixime, ceftazidime, ceftriaxone, gentamicin, levofloxacin, meropenem, metoclopramide, metronidazole, ranitidine, rosuvastatin, tazocin, tienam and vancomycin. Conclusions: The dosing of more than half of the medications that need dosing adjustment in CKD were not adjusted which can increase the side effects and toxicity of these drugs for CKD patients. It is the pharmacist duty by co-operation with the medical team to ensure the prescribing of optimal dose.

Item Type: Article
Subjects: Pharmacy
Divisions: College of Pharmacy > Pharmacy
Depositing User: KHALED ALAKHALI
Date Deposited: 20 Aug 2017 08:45
Last Modified: 20 Aug 2017 08:45
URI: http://eprints.kku.edu.sa/id/eprint/913

Actions (login required)

View Item View Item